Worth reading
37Immaterial
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
500
share acquisition rightsWording
Conditional
How definitive the wording is.Details of issuance or disposal
Issuance of share acquisition rights as stock options
Who receives how much
The number of underlying shares is 100 shares of the Company's common stock per share acquisition right. As 500 rights will be issued, the maximum is 50,000 shares. However, treasury shares are expected to be used instead of issuing new shares.
9 directors of the Company (excluding outside directors)445
7 executive officers55
The height of each bar represents the proportion of shares received by each allottee. The thin line below represents the number of existing shares to which these shares are added.
No cost (no monetary payment is required in exchange for the share acquisition rights)
Total issue value
No consideration
Terms of the stock acquisition rights
Exercise price
The initial exercise price will be finalized on 24 July 2026. Adjustment provisions apply in the event of a share split or consolidation, an issuance of new shares or disposal of treasury shares at a price below market value, or similar events. The floor for adjustments is Not disclosed.
Exercise period
From 25 July 2028 to 30 June 2035
Number of Stock Acquisition Rights
Total issued: 500; unexercised balance: Not disclosed
Reason for acquisition without consideration
If a merger agreement under which the Company becomes the disappearing company, or a share exchange agreement or share transfer plan under which the Company becomes a wholly owned subsidiary, is approved. Also, if it is determined before exercise that the exercise conditions will not be satisfied.
Categories and Number of Persons Covered
Category Directors of the company / Number of Employees 9 / Number of rights allotted 445, Category Executive officers / Number of Employees 7 / Number of rights allotted 55
Basis for determining the amount to be paid
The exercise price will be the average closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific exercise price per share is scheduled to be finalized on 24 July 2026.
Procedures under the Corporate Code of Conduct
The issuance of the share acquisition rights was approved at the ordinary general meeting of shareholders held on 26 June 2026.
Impact on Business Performance
The disclosure states that the purpose is to achieve sustained long-term performance improvements, but the specific amount or rate of the impact on performance or finances is Not disclosed.
| Item | Details |
|---|---|
| Type of issuance or disposal | Issuance of share acquisition rights as stock options |
| Number of shares to be issued or disposed of | The number of underlying shares is 100 shares of the Company's common stock per share acquisition right. As 500 rights will be issued, the maximum is 50,000 shares. However, treasury shares are expected to be used instead of issuing new shares. |
| Issue price and disposal price | No cost (no monetary payment is required in exchange for the share acquisition rights) |
| Total issue value | No consideration |
| Intended allottee | Category 9 directors of the Company (excluding outside directors) / Number of units 445, Category 7 executive officers / Number of units 55 |
| Basis for determining the amount to be paid | The exercise price will be the average closing price of the Company's common stock in regular trading on the Tokyo Stock Exchange on each trading day in the month preceding the month in which the allotment date falls, multiplied by 1.05. However, if this amount is below the closing price on the allotment date, the closing price on the allotment date will apply. The specific exercise price per share is scheduled to be finalized on 24 July 2026. |
| Exercise price | The initial exercise price will be finalized on 24 July 2026. Adjustment provisions apply in the event of a share split or consolidation, an issuance of new shares or disposal of treasury shares at a price below market value, or similar events. The floor for adjustments is Not disclosed. |
| Exercise period | From 25 July 2028 to 30 June 2035 |
| Number of Stock Acquisition Rights | Total issued: 500; unexercised balance: Not disclosed |
| Reason for acquisition without consideration | If a merger agreement under which the Company becomes the disappearing company, or a share exchange agreement or share transfer plan under which the Company becomes a wholly owned subsidiary, is approved. Also, if it is determined before exercise that the exercise conditions will not be satisfied. |
| Categories and Number of Persons Covered | Category Directors of the company / Number of Employees 9 / Number of rights allotted 445, Category Executive officers / Number of Employees 7 / Number of rights allotted 55 |
| Procedures under the Corporate Code of Conduct | The issuance of the share acquisition rights was approved at the ordinary general meeting of shareholders held on 26 June 2026. |
| Impact on Business Performance | The disclosure states that the purpose is to achieve sustained long-term performance improvements, but the specific amount or rate of the impact on performance or finances is Not disclosed. |
Items this document does not state (15)
Amount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesTransfer restriction periodConditions for lifting transfer restrictionsTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To further increase the motivation and morale of the Company's directors and executive officers to improve performance and achieve sustained long-term performance improvements.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.